Timely diagnosis and treatment of acute promyelocytic leukemia should be available to all

por Schuh, Andre C.
Publicado 2021

Venetoclax in Combination with Azacitidine for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: A Canadian Cost–Utility Analysis

por Guinan, Kimberly, Mathurin, Karine, Au, Yunghan, Schuh, Andre C., Bui, Cat N., Chai, Xinglei, Lachaine, Jean
Publicado 2022

Consensus Recommendations for MRD Testing in Adult B-Cell Acute Lymphoblastic Leukemia in Ontario

por Tierens, Anne, Stockley, Tracy L., Campbell, Clinton, Fulcher, Jill, Leber, Brian, McCready, Elizabeth, Sabatini, Peter J. B., Sadikovic, Bekim, Schuh, Andre C.
Publicado 2021

Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen

por Al Nabhani, Ibrahim, Andrews, Claire, Sibai, Jad, Atenafu, Eshetu, Young, Taylor, Chan, Steven M., Gupta, Vikas, Maze, Dawn, Schimmer, Aaron D., Schuh, Andre C., Yee, Karen, Sibai, Hassan
Publicado 2022

Survival outcomes with oral azacitidine maintenance in patients with acute myeloid leukemia in remission by receipt of initial chemotherapy: subgroup analyses from the phase III QU...

por Wei, Andrew H., Roboz, Gail J., Dombret, Hervé, Döhner, Hartmut, Schuh, Andre C., Montesinos, Pau, Selleslag, Dominik, Bondarenko, Sergey N., Prebet, Thomas, Lai, Yinzhi, Skikne, Barry, Beach, C.L., Ravandi, Farhad
Publicado 2023

Outcomes in Patients with Poor-Risk Cytogenetics with or without TP53 Mutations Treated with Venetoclax and Azacitidine

por Pollyea, Daniel A., Pratz, Keith W., Wei, Andrew H., Pullarkat, Vinod, Jonas, Brian A., Recher, Christian, Babu, Sunil, Schuh, Andre C., Dail, Monique, Sun, Yan, Potluri, Jalaja, Chyla, Brenda, DiNardo, Courtney D.
Publicado 2022

A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia

por Reed, Gregory A., Schiller, Gary J., Kambhampati, Suman, Tallman, Martin S., Douer, Dan, Minden, Mark D., Yee, Karen W., Gupta, Vikas, Brandwein, Joseph, Jitkova, Yulia, Gronda, Marcela, Hurren, Rose, Shamas‐Din, Aisha, Schuh, Andre C., Schimmer, Aaron D.
Publicado 2016

Biallelic disruption of DDX41 activity is associated with distinct genomic and immunophenotypic hallmarks in acute leukemia

por Tierens, Anne, Kagotho, Elizabeth, Shinriki, Satoru, Seto, Andrew, Smith, Adam C., Care, Melanie, Maze, Dawn, Sibai, Hassan, Yee, Karen W., Schuh, Andre C., Kim, Dennis Dong Hwan, Gupta, Vikas, Minden, Mark D., Matsui, Hirotaka, Capo-Chichi, José-Mario
Publicado 2023

Measurable residual disease monitoring provides insufficient lead-time to prevent morphological relapse in the majority of patients with core-binding factor acute myeloid leukemia

por Puckrin, Robert, Atenafu, Eshetu G., Claudio, Jaime O., Chan, Steven, Gupta, Vikas, Maze, Dawn, McNamara, Caroline, Murphy, Tracy, Schuh, Andre C., Yee, Karen, Sibai, Hassan, Minden, Mark D., Wei, Cuihong, Stockley, Tracy, Kamel-Reid, Suzanne, Schimmer, Aaron D.
Publicado 2020

Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free ALL Regimen

por Chen, Ruiqi, Liu, Xing, Law, Arjun D., Kanfar, Solaf, Maze, Dawn, Chan, Steven M., Gupta, Vikas, Yee, Karen W., Minden, Mark D., Schimmer, Aaron D., Schuh, Andre C., McNamara, Caroline J., Murphy, Tracy, Xu, Anna, Falcone, Umberto, Seki, Jack, Sibai, Hassan
Publicado 2020

Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine

por Pratz, Keith W., Jonas, Brian A., Pullarkat, Vinod, Recher, Christian, Schuh, Andre C., Thirman, Michael J., Garcia, Jacqueline S., DiNardo, Courtney D., Vorobyev, Vladimir, Fracchiolla, Nicola S., Yeh, Su-Peng, Jang, Jun Ho, Ozcan, Muhit, Yamamoto, Kazuhito, Illes, Arpad, Zhou, Ying, Dail, Monique, Chyla, Brenda, Potluri, Jalaja, Döhner, Hartmut
Publicado 2022

Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens

por Seymour, John F., Döhner, Hartmut, Butrym, Aleksandra, Wierzbowska, Agnieszka, Selleslag, Dominik, Jang, Jun Ho, Kumar, Rajat, Cavenagh, James, Schuh, Andre C., Candoni, Anna, Récher, Christian, Sandhu, Irwindeep, del Castillo, Teresa Bernal, Al-Ali, Haifa Kathrin, Falantes, Jose, Stone, Richard M., Minden, Mark D., Weaver, Jerry, Songer, Steve, Beach, C. L., Dombret, Hervé
Publicado 2017

Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation

por Iland, Harry J., Russell, Nigel, Dillon, Richard, Schuh, Andre C., Tedjaseputra, Aditya, Wei, Andrew, Khwaja, Asim, Knapper, Steven, Lane, Steven W., Reynolds, John, McMullin, Mary Frances, Martin, Annalise, Tan, Peter, Taussig, David C., Wong, Anny, Taper, John, Fraga, Christina, Kelly, Richard, Tawana, Kiran, Mehta, Priyanka, Mina, Alain, Altman, Jessica K., Mølle, Ingolf, Tauro, Sudhir, Tholouli, Eleni
Publicado 2022

Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial

por de Botton, Stéphane, Montesinos, Pau, Schuh, Andre C., Papayannidis, Cristina, Vyas, Paresh, Wei, Andrew H., Ommen, Hans, Semochkin, Sergey, Kim, Hee-Je, Larson, Richard A., Koprivnikar, Jaime, Frankfurt, Olga, Thol, Felicitas, Chromik, Jörg, Byrne, Jenny, Pigneux, Arnaud, Thomas, Xavier, Salamero, Olga, Vidriales, Maria Belen, Doronin, Vadim, Döhner, Hartmut, Fathi, Amir T., Laille, Eric, Yu, Xin, Hasan, Maroof, Martin-Regueira, Patricia, DiNardo, Courtney D.
Publicado 2023

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Aust...

por Pleyer, Lisa, Döhner, Hartmut, Dombret, Hervé, Seymour, John F., Schuh, Andre C., Beach, CL, Swern, Arlene S., Burgstaller, Sonja, Stauder, Reinhard, Girschikofsky, Michael, Sill, Heinz, Schlick, Konstantin, Thaler, Josef, Halter, Britta, Machherndl Spandl, Sigrid, Zebisch, Armin, Pichler, Angelika, Pfeilstöcker, Michael, Autzinger, Eva M., Lang, Alois, Geissler, Klaus, Voskova, Daniela, Sperr, Wolfgang R., Hojas, Sabine, Rogulj, Inga M., Andel, Johannes, Greil, Richard
Publicado 2017

Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia

por Pratz, Keith W., Panayiotidis, Panayiotis, Recher, Christian, Wei, Xudong, Jonas, Brian A., Montesinos, Pau, Ivanov, Vladimir, Schuh, Andre C., DiNardo, Courtney D., Novak, Jan, Pejsa, Vlatko, Stevens, Don, Yeh, Su-Peng, Kim, Inho, Turgut, Mehmet, Fracchiolla, Nicola, Yamamoto, Kazuhito, Ofran, Yishai, Wei, Andrew H., Bui, Cat N., Benjamin, Katy, Kamalakar, Rajesh, Potluri, Jalaja, Mendes, Wellington, Devine, Jacob, Fiedler, Walter
Publicado 2022

Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia

por DiNardo, Courtney D., Stein, Anthony S., Stein, Eytan M., Fathi, Amir T., Frankfurt, Olga, Schuh, Andre C., Döhner, Hartmut, Martinelli, Giovanni, Patel, Prapti A., Raffoux, Emmanuel, Tan, Peter, Zeidan, Amer M., de Botton, Stéphane, Kantarjian, Hagop M., Stone, Richard M., Frattini, Mark G., Lersch, Frederik, Gong, Jing, Gianolio, Diego A., Zhang, Vickie, Franovic, Aleksandra, Fan, Bin, Goldwasser, Meredith, Daigle, Scott, Choe, Sung, Wu, Bin, Winkler, Thomas, Vyas, Paresh
Publicado 2021

Identification of pre-leukemic hematopoietic stem cells in acute leukemia

por Shlush, Liran I., Zandi, Sasan, Mitchell, Amanda, Chen, Weihsu Claire, Brandwein, Joseph M., Gupta, Vikas, Kennedy, James A., Schimmer, Aaron D., Schuh, Andre C., Yee, Karen W., McLeod, Jessica L., Doedens, Monica, Medeiros, Jessie J.F., Marke, Rene, Kim, Hyeoung Joon, Lee, Kwon, McPherson, John D., Hudson, Thomas J., Brown, Andrew M.K., Trinh, Quang M., Stein, Lincoln D., Minden, Mark D., Wang, Jean C.Y., Dick, John E.
Publicado 2014

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

por Zeidan, Amer M, Boddu, Prajwal C, Patnaik, Mrinal M, Bewersdorf, Jan Philipp, Stahl, Maximilian, Rampal, Raajit K, Shallis, Rory, Steensma, David P, Savona, Michael R, Sekeres, Mikkael A, Roboz, Gail J, DeAngelo, Daniel J, Schuh, Andre C, Padron, Eric, Zeidner, Joshua F, Walter, Roland B, Onida, Francesco, Fathi, Amir, DeZern, Amy, Hobbs, Gabriela, Stein, Eytan M, Vyas, Paresh, Wei, Andrew H, Bowen, David T, Montesinos, Pau, Griffiths, Elizabeth A, Verma, Amit K, Keyzner, Alla, Bar-Natan, Michal, Navada, Shyamala C, Kremyanskaya, Marina, Goldberg, Aaron D, Al-Kali, Aref, Heaney, Mark L, Nazha, Aziz, Salman, Huda, Luger, Selina, Pratz, Keith W, Konig, Heiko, Komrokji, Rami, Deininger, Michael, Cirici, Blanca Xicoy, Bhatt, Vijaya Raj, Silverman, Lewis R, Erba, Harry P, Fenaux, Pierre, Platzbecker, Uwe, Santini, Valeria, Wang, Eunice S, Tallman, Martin S, Stone, Richard M, Mascarenhas, John
Publicado 2020